NUTRA PHARMA CORP (NPHC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 90K 180K 270K FY16: 168.4K FY17: 121K FY18: 130.6K FY19: 104.4K FY20: 51.9K FY21: 97.7K FY22: 145.8K FY23: 205.6K FY24: 246.3K FY25: 257.6K FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Gross Profit Annual

-150K 0 150K 300K 450K FY16: -54.6K FY17: 94.1K FY18: 14.1K FY19: 34.7K FY20: 14.9K FY21: 8.5K FY22: 249K FY23: 396.5K FY24: 247.3K FY25: 196.6K FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Operating Income Annual

-2.1M -1.4M -700K 0 700K 1.4M 2.1M FY16: -2M FY17: -1.4M FY18: -1.9M FY19: -1.2M FY20: -924.9K FY21: -2M FY22: -1.9M FY23: -887K FY24: -878.4K FY25: -1.5M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Net Income Annual

-15M -10M -5M 0 5M 10M 15M FY16: -3.4M FY17: -4M FY18: -3.9M FY19: -6.6M FY20: -769.2K FY21: -13.1M FY22: 8.2M FY23: -1.4M FY24: -1.3M FY25: -2M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Cost of Revenue Annual

0 70K 140K 210K FY14: 114.3K FY15: 65.8K FY16: 39K FY17: 26.9K FY18: 68.8K FY21: 41.3K FY22: 162.8K FY23: 177.5K FY24: 84.8K FY25: 183.7K FY14 FY15 FY16 FY17 FY18 FY21 FY22 FY23 FY24 FY25

Operating Cash Flow Annual

-1.8M -1.2M -600K 0 600K 1.2M 1.8M FY16: -1.4M FY17: -1.1M FY18: -999.9K FY19: -743.7K FY20: -878.1K FY21: -1.7M FY22: -762.4K FY23: -550K FY24: -424K FY25: -1.2M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Free Cash Flow Annual

-2.1M -1.4M -700K 0 700K 1.4M 2.1M FY11: -1.9M FY12: -721.2K FY14: -169.7K FY15: -1M FY16: -1.4M FY17: -1.1M FY20: -884K FY21: -1.8M FY22: -820.4K FY25: -1.2M FY11 FY12 FY14 FY15 FY16 FY17 FY20 FY21 FY22 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 7B 14B 21B FY21: 7.2B FY22: 19.1B FY23: 7.6B FY24: 7.7B FY25: 7.8B FY21 FY22 FY23 FY24 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.15 -0.10 -0.05 0.00 0.05 0.10 0.15 Q3 '16: -0.13 Q4 '16: -0.02 Q1 '17: -0.03 Q2 '17: -0.02 Q3 '17: -0.02 Q4 '17: 0.00 Q1 '18: 0.02 Q2 '18: 0.02 Q3 '18: 0.02 Q4 '18: 0.00 Q1 '19: 0.00 Q2 '19: 0.00 Q3 '19: 0.00 Q4 '19: 0.00 Q1 '20: 0.00 Q2 '20: 0.00 Q3 '20: 0.00 Q4 '20: 0.00 Q1 '21: 0.00 Q2 '21: 0.00 Q3 '21: 0.00 Q4 '21: 0.00 Q1 '22: 0.00 Q2 '22: 0.00 Q3 '22: 0.00 Q4 '22: 0.00 Q1 '23: 0.00 Q2 '23: 0.00 Q3 '23: 0.00 Q4 '23: 0.00 Q1 '24: 0.00 Q2 '24: 0.00 Q3 '24: 0.00 Q4 '24: 0.00 Q1 '25: 0.00 Q2 '25: 0.00 Q3 '25: 0.00 Q4 '25: 0.00 Q1 '26: 0.00 Q2 '26: 0.00 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.